Navigation Links
DermaGen AB Receives Over 1 Million Euros From a New Share Issue
Date:4/2/2008

ated prerequisites for a substantial, rapid and international break-through in the fields of Life Science, Security, and Clean Tech.

Midroc New Technology AB is part of Midroc Europe. The Group offers a wide range of management and contracting services to the civil and industrial market. In total the Group has 2 700 employees and an annual turnover amounting to SEK 4.0 billion.

About Karolinska Development

Karolinska Development commercializes Nordic life science innovation. Early stage investment enables value building through long term lead investor position, from seed stage to the market.

http://www.karolinskadevelopment.com

About the Ostersjostiftelsen

The Ostersjostiftelsen was established in 1994 by the Swedish government. In January 2007, the endowment's market value was approximately 7.1 billion Swedish kronor. There are two committees of the Board, one deals with finances and one for academic affairs. The Foundation is governed by a Board appointed by the Swedish government.

For further information please contact:

Jan Alenfall

CEO of DermaGen

ph: +46-46-286-4080

mobile: +46-709-315-115

e-mail: jan.alenfall@dermagen.se

Jonas Frick

Chairman of the Board

ph: +46-18-65-39-01

e-mail: info@dermagen.se

Goran Linder

CEO of Midroc New Technology AB

ph: +46-8-706-7450


'/>"/>
SOURCE DermaGen AB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
2. Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
3. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
4. Florastor(R) Receives ConsumerLab.com Certification
5. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
6. Vermillion Receives Award From the Society of Gynecologic Oncologists
7. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
8. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
9. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Boehringer Ingelheim will contribute to advancing the ... Thoracic Society International Conference (ATS 2013) in ... 22. Data will highlight research conducted ... chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler® (tiotropium ... for asthma, idiopathic pulmonary fibrosis (IPF) and COPD. ...
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation ... at the annual EuroPCR Scientific Program May 21-24 in ... pleased to present a particularly rich and diversified set ... Keith Dawkins , M.D., global chief medical officer, ... will be presented, including the NG PROMUS trial, which ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
... Calif., March 15, 2011 XTIO2 INC ... -nominees with the XTI ANTI-GERM / ANTI-VOC / ... and XTI™  Nano-Facemask . It is the ... against germs transmitted via air and contact surfaces. The ...
... FRANCISCO, March 15, 2011 Motion Therapeutics, Inc. ... for balance and mobility disorders, today announced that researchers ... a NIH Recovery Act Grant to study the effects ... and mobility in people with MS. ...
Cached Medicine Technology:OSCAR® Nominees Receive (XTIO2 INC.) XTI 360™ Nano Coating Anti-Germ System 2OSCAR® Nominees Receive (XTIO2 INC.) XTI 360™ Nano Coating Anti-Germ System 3The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant 2
(Date:5/18/2013)... 18, 2013 Although obesity is associated ... association between obesity and esophageal adenocarcinoma, a type of ... tumors. As reported on Cancer.gov, last reviewed ... twice as likely as those of normal and healthy ... between obesity and esophageal cancer is not well understood, ...
(Date:5/18/2013)... Show And Go Training, the culmination of ... systems that is all about is getting results in the ... http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting an investigative review. ... “four phase system” designed to make you faster, stronger, fitter ... working out in the gym. The training manual and exercise ...
(Date:5/18/2013)... 18, 2013 Losing weight remains to be ... the horde of new weight loss products available in the ... Recent studies about this newest weight loss supplement prove that ... shape. , Garcinia Cambogia is a sub-tropical fruit that is ... the fruit can suppress a person’s appetite, while it effectively ...
(Date:5/18/2013)... 2013 John Ravera, D.D.S., a Newport ... a new member to his dental team, Courtney Marino. , ... field for over 10 years. She received her degree from ... elected a member of Sigma Pi Alpha, a national honor ... working with patients of all ages, helping them understand the ...
(Date:5/18/2013)... Medical device company, FlexLeg, LLC, last week began taking reservations ... its namesake, the FlexLeg. The device uses technology from ... injured individuals can use to walk on various terrains. Those ... walk during a typical 6-8 week recovery period , FlexLeg’s ... who need the device most are able to reserve one ...
Breaking Medicine News(10 mins):Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:FlexLeg Begins Offering New Mobility Aid 2
... Feb. 10 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. ... 9, 2009, following a bench trial, the district court entered ... Par in the amount of $69,955,476. As a result ... approximately $28 million on an after-tax basis in the fourth ...
... suite includes one-of-a-kind claims processing, business intelligence, ... truly compete in the 21st-century healthcare marketplaceBURLINGTON, ... the only modern, enterprise-class software platform for ... Services has selected the HealthRules product suite ...
... 10 SurgiQuest, Inc. AirSeal Dynamic Pressure System(TM) ... The AirSeal DPS(TM) continuously re-circulates and filters CO2 ... procedures.Surgeons routinely have to interrupt laparoscopic surgical procedures ... and plume within the operative environment. This impairment ...
... with a range of uptime and virtualization solutionsMAYNARD, ... that it is partnering with Massachusetts-based Infinity Healthcare ... products for uptime reliability as part of its ... services provider specializing in systems integration, software development, ...
... HMS (Nasdaq: HMSY ) today announced that ... Health Providers and Optima Health, a Sentara service -- ... portfolio. HMS will provide these services to Neighborhood Health ... Plan in Virginia.HMS will identify health insurance coverage not ...
... Zeus, Inc. is pleased to introduce its ... and accessible via http://www.zeusinc.com .With innovative graphics ... resource for comprehensive information about Zeus products and ... organizes an extensive amount of information into four ...
Cached Medicine News:Health News:Par Pharmaceutical Announces Outcome of the Litigation With Pentech Pharmaceuticals 2Health News:Mississippi Administrative Services Chooses the HealthRules(R) Product Suite from HealthEdge(R) to Address Next-Generation Business Needs 2Health News:SurgiQuest Announces FDA Approval for Smoke & Plume Evacuation for AirSeal Dynamic Pressure System(TM) 2Health News:Stratus Technologies Partners With Infinity Healthcare Solutions to Resell Availability Products With Its Services 2Health News:Stratus Technologies Partners With Infinity Healthcare Solutions to Resell Availability Products With Its Services 3Health News:HMS Awarded New Contracts for Managed Care Services 2
Provides a combination of concentrated cold / hot and compression for the neck...
Provides a combination of concentrated cold / hot and compression for the back...
... One-Piece™ Collar is completely injected molded from ... our patented chin support. , ,Our ... efficiently managed where space is limited. Color-coded ... of sizes., ,Either in a supine ...
... optional hot and cold therapy Gel Pad. Our ... providing cold therapy to reduce swelling and /or ... recovery., ,To order hot and cold therapy ... number., ,Our suspenders can be added to ...
Medicine Products: